Artivion, Inc. (AORT) stock
AORTNYSESurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 6, 2026Score 11/303% below fair value
$18.54+0.27 (+1.48%)
Close on Nov 18, 2026Market cap $903.94MP/E –Yield –
Artivion gross profit
Gross profit is revenue minus the direct cost of the goods and services sold.
Artivion's gross profit for the twelve months ending Jun 30, 2026 was $303.50M, up 17.1% year over year. For fiscal 2025 it was $284.23M, up 14.2% from the year before. Over ten years it grew 12.1% a year on average. The highest annual figure on record is $284.23M in fiscal 2025.
Annual gross profit
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $284.23M | +14.2% |
| FY2024 | Dec 31, 2024 | $248.78M | +8.6% |
| FY2023 | Dec 31, 2023 | $229.18M | +13.2% |
| FY2022 | Dec 31, 2022 | $202.52M | +2.5% |
| FY2021 | Dec 31, 2021 | $197.51M | +17.7% |
| FY2020 | Dec 31, 2020 | $167.78M | -8.3% |
| FY2019 | Dec 31, 2019 | $183.01M | +5.8% |
| FY2018 | Dec 31, 2018 | $172.98M | +34.5% |
| FY2017 | Dec 31, 2017 | $128.64M | +8.2% |
| FY2016 | Dec 31, 2016 | $118.90M | +31.1% |
| FY2015 | Dec 31, 2015 | $90.72M | -0.6% |
| FY2014 | Dec 31, 2014 | $91.29M | +1.0% |
| FY2013 | Dec 31, 2013 | $90.39M | +6.3% |
| FY2012 | Dec 31, 2012 | $85.02M | +12.1% |
| FY2011 | Dec 31, 2011 | $75.84M | +10.9% |
| FY2010 | Dec 31, 2010 | $68.37M | -2.0% |
| FY2009 | Dec 31, 2009 | $69.77M | – |
Quarterly gross profit
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $80.52M | +10.1% |
| Q1 FY2026 | Mar 31, 2026 | $75.45M | +18.7% |
| Q4 FY2025 | Dec 31, 2025 | $73.14M | +18.9% |
| Q3 FY2025 | Sep 30, 2025 | $74.40M | +21.9% |
| Q2 FY2025 | Jun 30, 2025 | $73.11M | +15.5% |
| Q1 FY2025 | Mar 31, 2025 | $63.58M | +1.0% |
| Q4 FY2024 | Dec 31, 2024 | $61.50M | +0.7% |
| Q3 FY2024 | Sep 30, 2024 | $61.01M | +8.4% |
| Q2 FY2024 | Jun 30, 2024 | $63.32M | +9.0% |
| Q1 FY2024 | Mar 31, 2024 | $62.95M | +17.2% |
| Q4 FY2023 | Dec 31, 2023 | $61.10M | +20.1% |
| Q3 FY2023 | Sep 30, 2023 | $56.27M | +15.4% |
| Q2 FY2023 | Jun 30, 2023 | $58.08M | +11.3% |
| Q1 FY2023 | Mar 31, 2023 | $53.73M | +5.9% |
| Q4 FY2022 | Dec 31, 2022 | $50.89M | -0.9% |
| Q3 FY2022 | Sep 30, 2022 | $48.74M | +2.0% |
| Q2 FY2022 | Jun 30, 2022 | $52.17M | +3.3% |
| Q1 FY2022 | Mar 31, 2022 | $50.72M | +6.0% |
| Q4 FY2021 | Dec 31, 2021 | $51.37M | +15.2% |
| Q3 FY2021 | Sep 30, 2021 | $47.79M | +10.8% |
| Q2 FY2021 | Jun 30, 2021 | $50.51M | +40.7% |
| Q1 FY2021 | Mar 31, 2021 | $47.84M | +8.3% |
| Q4 FY2020 | Dec 31, 2020 | $44.59M | -4.2% |
| Q3 FY2020 | Sep 30, 2020 | $43.13M | -4.6% |
| Q2 FY2020 | Jun 30, 2020 | $35.89M | -23.6% |
| Q1 FY2020 | Mar 31, 2020 | $44.17M | -0.2% |
| Q4 FY2019 | Dec 31, 2019 | $46.55M | +3.0% |
| Q3 FY2019 | Sep 30, 2019 | $45.22M | +5.9% |
| Q2 FY2019 | Jun 30, 2019 | $46.97M | +2.4% |
| Q1 FY2019 | Mar 31, 2019 | $44.27M | +12.9% |
| Q4 FY2018 | Dec 31, 2018 | $45.19M | +24.3% |
| Q3 FY2018 | Sep 30, 2018 | $42.71M | +43.0% |
| Q2 FY2018 | Jun 30, 2018 | $45.85M | +39.3% |
| Q1 FY2018 | Mar 31, 2018 | $39.23M | +32.9% |
| Q4 FY2017 | Dec 31, 2017 | $36.36M | +16.6% |
| Q3 FY2017 | Sep 30, 2017 | $29.86M | +0.3% |
| Q2 FY2017 | Jun 30, 2017 | $32.91M | – |
| Q1 FY2017 | Mar 31, 2017 | $29.51M | – |
| Q4 FY2016 | Dec 31, 2016 | $31.20M | – |
| Q3 FY2016 | Sep 30, 2016 | $29.78M | – |
See a number that looks wrong?